Bioclin

What Bioclin does

Bioclin (legal name Quibasa – Química Básica Ltda.) is a Brazilian in vitro diagnostics manufacturer founded in 1977 in Belo Horizonte, Minas Gerais by Dr. Victor Arndt, a PhD in Organic Chemistry from the University of Munich and former professor at the Federal University of Minas Gerais. The company produces more than 200 diagnostic kits organized into branded product lines including BIOGENE (real-time PCR molecular diagnostics), BIOLISA (ELISA immunoassays), Bioclin Fast (rapid antigen tests including COVID-19), BIOPOCT (point-of-care), CLIA (chemiluminescence), HEMATOLOGIA, COAGULACAO, BIOQUIMICA (clinical chemistry), AGLUTINACAO (latex agglutination), EQUIPAMENTOS (analyzers), and veterinary counterparts VetLISA, VetFast, and BIOQUIMICA VETERINARIO. Manufacturing occupies a 2,800 sq meter facility in the Pampulha region of Belo Horizonte, expanded from an initial 120 sq meter operation with 10 employees and 17 products.

The company's core technology spans the major IVD modalities — immunodiagnostics, molecular diagnostics (PCR with quantitative viral-load output), rapid tests, clinical chemistry, hematology, and coagulometry — and it serves both human and veterinary diagnostic markets. Recent product activity includes the August 2022 launch of the BIOCLIN FAST COVID-19 Ag Autoteste for at-home use and the Bio Gene Chikungunya PCR Kit for quantitative viral-load detection.

Bioclin operates a B2B model selling diagnostic kits to clinical analysis laboratories through a domestic distributor network, supplemented by direct e-commerce sales (loja.bioclin.com.br) and retail pharmacy distribution for consumer-facing autotests. A BULK and OEM offering enables white-label supply to other IVD brands. Pricing is not publicly disclosed; B2B wholesale and distributor pricing is negotiated through the sales team, while retail consumer autotests are priced between R$1.99 and R$99.00 on the e-commerce platform. The company pursues international visibility through trade-fair participation at MEDITECH (Colombia), AACC (Chicago), FIME (Miami), and MEDICA (Düsseldorf), though primary revenue concentration remains domestic Brazil.

Name

Bioclin

Legal name

Quibasa – Química Básica Ltda.

Website

https://bioclin.com.br

Company type

Private

Founded year

1977

Operating status

Operating

Headcount range

101–250 employees

Short description

Bioclin (Quibasa – Química Básica Ltda.) is a privately held Brazilian in vitro diagnostics manufacturer founded in 1977, producing 200+ diagnostic kits across ELISA, PCR, rapid tests, hematology, clinical chemistry, and veterinary lines for clinical laboratories and point-of-care users in Brazil.

Ownership category

akta.pro rank

Product category

In Vitro Diagnostics

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413)

SIC

In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry) (HLAGAEAB)

akta.pro secondary industry

Compounding Pharmacies (Veterinary) (HLAMAIAD)

Keywords

• In vitro diagnostics
• Clinical chemistry reagents
• Molecular diagnostic kits
• Immunodiagnostic reagents
• Rapid test kits

Headquarters

HQ city

Belo Horizonte

HQ country

Brazil

HQ region

Latin America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Supply Chain, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Diagnostic Kit Sales: Quibasa-Bioclin generates revenue through the manufacture and sale of in vitro diagnostic kits to clinical analysis laboratories. The company sells directly through its e-commerce platform and through a network of distributors, serving both human and veterinary diagnostic markets.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels5 records

Core offering

Quibasa-Bioclin manufactures and develops in vitro diagnostic kits for clinical analysis laboratories in Brazil and select international markets. The portfolio spans immunodiagnostics (ELISA, CLIA, latex agglutination), molecular diagnostics (real-time PCR), rapid antigen tests, point-of-care testing, hematology, coagulation, and clinical chemistry reagents for both human and veterinary use. The company sells primarily B2B through a distributor network and its own e-commerce platform, with selected consumer products (e.g., COVID-19 self-tests) available through Brazilian pharmacies.

Product overview

Bioclin (Quibasa-Bioclin) is a Brazilian in vitro diagnostics manufacturer founded in 1977, producing over 200 diagnostic products for clinical analysis laboratories. The company operates a multi-product portfolio organized into distinct diagnostic lines: molecular diagnostics under BIOGENE (including Bio Gene Chikungunya PCR Kit and BIOGENE RESEARCH); rapid testing via Bioclin Fast (including BIOCLIN FAST COVID-19 Ag Autoteste); immunoassays including BIOLISA (ELISA), CLIA (chemiluminescence), AGLUTINACAO (latex agglutination), and BIOPOCT (point-of-care); hematology and coagulation testing (HEMATOLOGIA, COAGULACAO); biochemistry diagnostics (BIOQUIMICA for human and veterinary use); equipment/analyzers; and specialized offerings (BIOCLIN CARE, BULK/OEM). The portfolio serves both human and veterinary diagnostic markets.

Differentiator

Problem solved

Functional benefit

Brands

• Bioclin Fast: Rapid test product line including COVID-19 Ag self-test
• Bio Gene
• BioLISA
• BioPOCT
• BioGene Research
• Bioclin Care
• Bioclin Educar
• VetLISA
• VetFast
• Bioquímica
• Hematologia
• Coagulação
• Aglutinação
• CLIA
• BULK e OEM
• Equipamentos

Products and services

• BIOLISA ELISA-based immunodiagnostic kits for clinical analysis laboratories covering infectious disease and other immunology markers.
• BIOPOCT Point-of-care diagnostic product line for rapid testing at clinical settings, enabling results without centralized laboratory processing.
• Bioclin Fast Rapid test product line including COVID-19 antigen tests and other point-of-care diagnostics for clinical use and consumer self-testing.
• BIOGENE Molecular diagnostic product line using PCR technology for pathogen detection, including the Bio Gene Chikungunya PCR Kit.
• BIOGENE RESEARCH Research-grade molecular diagnostic reagents available by request, intended for research and advanced laboratory applications.
• AGLUTINAÇÃO (Latex Agglutination) Latex agglutination diagnostic products for immunodiagnostic testing in clinical laboratories.
• HEMATOLOGIA Hematology diagnostic products and analyzers for clinical laboratories performing blood cell analysis.
• COAGULAÇÃO Coagulation diagnostic products for blood clotting analysis in clinical laboratories.
• BIOQUÍMICA Biochemistry diagnostic products for clinical chemistry analysis, including assays for a range of biochemical markers.
• BIOQUÍMICA VETERINÁRIO Veterinary biochemistry diagnostic products for animal health testing in veterinary laboratories.
• CLIA Chemiluminescence immunoassay diagnostic products for sensitive detection of a wide range of analytes in clinical laboratories.
• EQUIPAMENTOS Diagnostic equipment including analyzers and instruments for clinical laboratories to run Bioclin reagent kits.
• BULK e OEM Bulk and OEM diagnostic reagents for custom manufacturing and white-label supply to other diagnostic companies.
• BIOCLIN CARE Specialized diagnostic product line under the Bioclin Care branding for healthcare consumer applications.
• BIOCLIN FAST COVID-19 Ag Autoteste Rapid antigen self-test for COVID-19 detection intended for at-home consumer use, providing quick results to identify infection and limit virus transmission.
• Bio Gene Chikungunya PCR Kit Real-time PCR diagnostic kit for Chikungunya virus detection in clinical samples, capable of quantifying viral load (copies/µl) even at low viral loads during the early symptomatic phase.
• VetLISA ELISA-based immunodiagnostic kits for veterinary laboratory use, covering animal health testing.
• VetFast Rapid test product line for veterinary applications, enabling quick on-site animal health screening.

Named customers1 record

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Scale indicators4 records

Recent moves5 records

Expansion highlights6 records

Direct peers

• Laborclin: Brazilian IVD manufacturer headquartered in Paraná producing reagents and kits for clinical chemistry, immunology, hematology, and rapid testing. Directly comparable to Bioclin as a domestic multi-platform IVD kit producer serving Brazilian clinical laboratories.
• Gold Analisa: Brazilian in vitro diagnostics manufacturer with a broad reagent portfolio across clinical chemistry, immunology, and hematology, plus equipment. Comparable to Bioclin as a Brazilian multi-line IVD competitor targeting the same hospital and lab customer base.
• Celer Biotecnologia: Brazilian molecular diagnostics and life sciences manufacturer specializing in PCR kits and reagents. Comparable to Bioclin's BioGene molecular diagnostic line and targets overlapping Brazilian lab customers.

Regional players

• Wiener Laboratorios: Argentine IVD manufacturer with a broad clinical chemistry, immunology, and hematology portfolio distributed across Latin America. Comparable as a regional Latin American IVD kit producer competing with Bioclin in cross-border lab tenders.

Broad incumbents

• bioMérieux: Global IVD company focused on microbiology, immunoassays, and molecular diagnostics. Comparable to Bioclin's immunology and molecular product lines as a broader incumbent with overlapping offerings in Brazilian hospital labs.
• Roche Diagnostics: Largest global IVD player across immunoassays, clinical chemistry, molecular, and hematology. Comparable to Bioclin across nearly every product category but with installed-base analyzer lock-in in Brazilian hospital and reference labs.
• Abbott Diagnostics: Global IVD manufacturer with strong immunoassay, rapid test, and molecular diagnostics franchises. Comparable to Bioclin's CLIA, ELISA, and rapid test product lines and competes in the same Brazilian clinical lab market.
• Siemens Healthineers: Global IVD and imaging company with a large reagent menu in clinical chemistry, immunoassay, and hematology. Comparable to Bioclin's chemistry and hematology lines as an incumbent in Brazilian hospital accounts.
• Danaher (Beckman Coulter Diagnostics): Global diagnostics franchise within Danaher covering immunoassay, clinical chemistry, hematology, and microbiology. Comparable to Bioclin's chemistry, immunoassay, and hematology product lines in mid- and high-volume labs.

Emerging players

• Mindray: Chinese-origin global IVD and medical device company expanding aggressively in Latin America with clinical chemistry, immunoassay, and hematology analyzers and reagents. Comparable to Bioclin as a competitively priced alternative in Brazilian hospital tenders.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/c/BioclinDiagnostica
• Facebookfacebook.com/bioclinglobal
• LinkedInlinkedin.com/company/bioclin
• Instagraminstagram.com/bioclinglobal

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bioclin